Neurogenic Detrusor Overactivity
📧 Sign up to get email alerts when something new happens for Neurogenic Detrusor Overactivity.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-11-17Clinical Trial Update: Is the Nerve Growth Factor (NGF) a Useful Biomarker in Neurogenic Bladder Dysfunction After Spinal Cord Injury?
This clinical trial update discusses whether nerve growth factor (NGF) can serve as a biomarker for neurogenic bladder dysfunction after spi…
-
CLINICAL_TRIALS trial_result · 2015-03-24Clinical Trial Update: NEUROTOX: Two Dosages of Type A Botulinic Toxin in Neurogenic Overactive Bladder [Phase 2]
Phase 2 trial testing two doses of botulinum toxin type A for neurogenic overactive bladder was terminated.
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: Study of Darifenacin in Patients Suffering From Multiple Sclerosis and Neurogenic Detrusor Overactivity [Phase 2]
Phase 2 study of darifenacin in patients with multiple sclerosis and neurogenic detrusor overactivity was terminated.
-
CLINICAL_TRIALS trial_result · 2014-11-06Clinical Trial Update: The Interest of the Nitrous Oxide During Intravesical Injection of Botulinum Toxin A [Phase 3]
This report covers a Phase 3 trial evaluating nitrous oxide as an analgesic aid during intravesical injections of botulinum toxin A. The stu…
-
CLINICAL_TRIALS trial_result · 2014-10-09Clinical Trial Update: Study to Determine Pharmacodynamic Effects and Pharmacokinetics of KUC 7483 CL in Patients With Spinal Cord Injury and Neurogenic Detrusor Overactivity [Phase 1]
Phase 1 pharmacodynamic and pharmacokinetic study of KUC 7483 CL in patients with spinal cord injury and neurogenic detrusor overactivity; s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-09-01Clinical Trial Update: Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis [Phase 2]
Phase 2 clinical trial update on neurogenic detrusor overactivity after spinal cord injury or multiple sclerosis; results posted in 2014.
-
FDA approval · 2013-07-31FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for oxybutynin chloride from Upsher-Smith Laboratories, LLC.
-
CLINICAL_TRIALS trial_result · 2013-07-31Clinical Trial Update: Extended-Release Oxybutynin for the Treatment of Neurogenic Detrusor Overactivity [Phase 4]
This Phase 4 trial of extended-release oxybutynin for neurogenic detrusor overactivity was terminated. Results were posted in July 2013.
-
CLINICAL_TRIALS trial_result · 2013-04-08Clinical Trial Update: Comparative Study of the Efficacy and Safety of Muscarinic M3 Receptors Antagonists in the Treatment of Neurogenic Detrusor Overactivity [Phase 4]
Phase 4 clinical trial update evaluating the efficacy and safety of muscarinic M3 receptor antagonists for neurogenic detrusor overactivity …
-
CLINICAL_TRIALS trial_result · 2012-02-10Clinical Trial Update: Efficacy and Tolerability of Propiverine Hydrochloride in Patients With Neurogenic Detrusor Overactivity [Phase 3]
Phase 3 trial evaluating propiverine hydrochloride for neurogenic detrusor overactivity has completed.
-
CLINICAL_TRIALS trial_result · 2011-11-22Clinical Trial Update: A Comparison Study of Oxybutynin and Botulinum Toxin for Neurogenic Detrusor Overactivity [NA]
This completed trial compared oxybutynin and botulinum toxin for neurogenic detrusor overactivity in individuals with spinal cord injury.
-
CLINICAL_TRIALS trial_result · 2011-11-17Clinical Trial Update: Study Of Fesoterodine In Pediatric Overactive Bladder Patients Aged 8-17 Years [Phase 2]
Phase 2 clinical trial of fesoterodine in pediatric patients (ages 8-17) with overactive bladder or neurogenic detrusor overactivity has bee…
-
CLINICAL_TRIALS trial_result · 2010-04-30Clinical Trial Update: A Study Evaluating Oxybutynin in Patients With Neurogenic Overactive Bladder Associated With a Neurological Condition [Phase 4]
Phase 4 study evaluating oxybutynin for neurogenic detrusor overactivity has completed, with results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-03-24Clinical Trial Update: Intravesical Injection of Botulinum Toxin A Versus Saline for Neurogenic Detrusor Overactivity [Phase 3]
A Phase 3 trial comparing intravesical injections of botulinum toxin A to saline for neurogenic detrusor overactivity has completed.